Nmda antagonists for the treatment of mental disorders with occurrence of aggressive and/or impulsive behavior

Abstract

The present invention relates to the use of N-Methyl-D-aspartate (NMDA) antagonists at sub-anesthetic doses for the treatment of mental disorders with occurrence of aggressive and/or impulsive behavior